Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -39.97%-91.33M | ---- | 4.27%-65.25M | ---- | 34.39%-68.16M | ---- | -414.74%-103.88M | ---- | -21.76%33.01M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 63.89%-26K | ---- | -157.14%-72K | ---- | -86.67%-28K | ---- | 88.37%-15K | ---- | 84.51%-129K |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.02%2.13M | ---- | 0.26%1.18M |
| Impairment and provisions: | ---- | 36.61%66.08M | ---- | -30.45%48.37M | ---- | -39.90%69.56M | ---- | 5,592.38%115.73M | ---- | 189.19%2.03M |
| -Impairment of property, plant and equipment (reversal) | ---- | -53.62%13.08M | ---- | --28.2M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | 109.30%5.49M | ---- | --2.62M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5,521.10%114.28M | ---- | 189.19%2.03M |
| -Other impairments and provisions | ---- | 170.67%47.51M | ---- | -74.76%17.55M | ---- | 4,700.21%69.56M | ---- | --1.45M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | 66.67%-2.15M | ---- | ---6.46M | ---- | ---- |
| -Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---2.15M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.46M | ---- | ---- |
| Depreciation and amortization: | ---- | -38.98%5.63M | ---- | -45.44%9.22M | ---- | -17.69%16.9M | ---- | -11.00%20.54M | ---- | -9.75%23.07M |
| Financial expense | ---- | -15.92%1.59M | ---- | -20.28%1.89M | ---- | --2.37M | ---- | ---- | ---- | ---- |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.69M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -209.53%-18.06M | ---- | -131.54%-5.83M | ---- | -27.05%18.49M | ---- | -57.15%25.35M | ---- | -14.00%59.16M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 5,092.73%17.18M | ---- | -103.91%-344K | ---- | 124.76%8.79M | ---- | -218.52%-35.5M | ---- | -6.91%29.96M |
| Accounts receivable (increase)decrease | ---- | -45.47%13.91M | ---- | -58.49%25.51M | ---- | 534.00%61.45M | ---- | 109.99%9.69M | ---- | -65.78%-97.02M |
| Accounts payable increase (decrease) | ---- | -155.72%-13.58M | ---- | 60.81%-5.31M | ---- | -135.12%-13.55M | ---- | 218.06%38.57M | ---- | -96.76%-32.67M |
| prepayments (increase)decrease | ---- | 266.75%20.8M | ---- | 37.74%-12.48M | ---- | 76.27%-20.04M | ---- | ---84.45M | ---- | ---- |
| Special items for working capital changes | ---- | 85.25%-528K | ---- | -324.25%-3.58M | ---- | -40.56%1.6M | ---- | 837.64%2.69M | ---- | -538.55%-364K |
| Cash from business operations | ---- | 1,071.39%19.73M | ---- | -103.58%-2.03M | ---- | 229.98%56.74M | ---- | -6.62%-43.66M | ---- | -257.94%-40.95M |
| Other taxs | ---- | 101.87%63K | ---- | -122.77%-3.38M | ---- | 45.89%-1.52M | ---- | 71.49%-2.8M | ---- | -154.98%-9.82M |
| Special items of business | -460.77%-11.06M | ---- | -138.43%-1.97M | ---- | -70.16%5.13M | ---- | 132.75%17.21M | ---- | -9.15%-52.54M | ---- |
| Net cash from operations | -460.77%-11.06M | 466.11%19.79M | -138.43%-1.97M | -109.79%-5.41M | -70.16%5.13M | 218.88%55.23M | 132.75%17.21M | 8.49%-46.46M | -9.15%-52.54M | -330.00%-50.77M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -26.67%11K | -63.89%26K | -65.91%15K | 157.14%72K | 528.57%44K | 86.67%28K | -22.22%7K | -89.73%15K | -93.23%9K | -83.60%146K |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | --374K | --2.58M | ---- | ---- | ---- |
| Purchase of fixed assets | -108.03%-285K | 99.16%-151K | 98.15%-137K | -1,638.10%-17.89M | -4,686.45%-7.42M | 51.12%-1.03M | 73.73%-155K | 94.39%-2.11M | 97.98%-590K | 49.38%-37.51M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --133K | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -124.59%-274K | 99.30%-125K | 98.35%-122K | -3,505.87%-17.81M | -403.00%-7.38M | 76.36%-494K | 518.93%2.43M | 94.41%-2.09M | 98.00%-581K | 48.96%-37.36M |
| Net cash before financing | -441.19%-11.34M | 184.70%19.67M | 6.51%-2.1M | -142.42%-23.22M | -111.41%-2.24M | 212.75%54.74M | 136.97%19.64M | 44.92%-48.55M | 31.23%-53.12M | -72.35%-88.13M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 2.07%31.36M | -35.84%56.38M | -40.14%30.73M | -25.89%87.87M | -10.78%51.33M | -19.71%118.58M | -19.61%57.54M | 87.26%147.69M | 13.30%71.57M | 44.48%78.87M |
| Refund | 23.12%-27.41M | 35.66%-68.4M | 48.73%-35.65M | 11.32%-106.32M | -5.35%-69.53M | -13.54%-119.88M | -109.19%-66M | -23.16%-105.58M | 56.78%-31.55M | -84.54%-85.73M |
| Interest paid - financing | 45.06%-445K | 15.92%-1.59M | 17.60%-810K | 20.28%-1.89M | 26.42%-983K | -11.52%-2.37M | -116.53%-1.34M | -81.02%-2.13M | 18.06%-617K | -0.26%-1.18M |
| Net cash from financing operations | 161.22%3.51M | 33.07%-13.61M | 70.11%-5.73M | -58.24%-20.34M | -6.13%-19.18M | -137.11%-12.85M | -154.90%-18.07M | 308.75%34.63M | 346.98%32.92M | -281.88%-16.59M |
| Effect of rate | 74.89%1.63M | -2,277.78%-2.78M | 278.89%932K | -105.14%-117K | -6.98%-521K | 423.76%2.28M | -35.28%-487K | 72.73%-703K | 89.89%-360K | -158.78%-2.58M |
| Net Cash | 0.00%-7.83M | 113.90%6.06M | 63.46%-7.83M | -203.99%-43.55M | -1,468.01%-21.42M | 400.96%41.88M | 107.75%1.57M | 86.71%-13.92M | 77.70%-20.2M | -88.76%-104.72M |
| Begining period cash | 22.60%17.76M | -75.09%14.49M | -75.09%14.49M | 315.43%58.16M | 315.43%58.16M | -51.08%14M | -51.08%14M | -78.94%28.62M | -78.94%28.62M | -27.32%135.92M |
| Cash at the end | 52.31%11.57M | 22.60%17.76M | -79.03%7.59M | -75.09%14.49M | 140.18%36.22M | 315.43%58.16M | 87.18%15.08M | -51.08%14M | -80.72%8.06M | -78.94%28.62M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.